Exozymes (EXOZ) EBIT Margin (2023)
Exozymes (EXOZ) posted quarterly EBIT Margin of 140721.0% for Q4 2023.
Exozymes (EXOZ) EBIT Margin (2023) Analysis & Trends
Exozymes (EXOZ) has reported EBIT Margin for 1 consecutive years, with 140721.0% the latest figure, recorded in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.75% |
| 10 | Exozymes | 64.09 Mn | 64.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 140,721.00% |